Maura Camozzi

Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis

Marco Rusnati, Maura Camozzi, Emanuela Moroni et al. · Blood · 2004 · 185 citations

Life Sciences, Cell Biology, Pharmacology +10

Identification of an Antiangiogenic FGF2-binding Site in the N Terminus of the Soluble Pattern Recognition Receptor PTX3

Maura Camozzi, Marco Rusnati, Antonella Bugatti et al. · Journal of Biological Chemistry · 2006 · 108 citations · Full text

Life Sciences, Cell Biology, Cell Signaling +14

Pentraxin 3 Inhibits Fibroblast Growth Factor 2–Dependent Activation of Smooth Muscle Cells In Vitro and Neointima Formation In Vivo

Maura Camozzi, Serena Zacchigna, Marco Rusnati et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 104 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +15

Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

Guy Jérusalem, Gabriella Mariani, Eva Ciruelos et al. · Annals of Oncology · 2016 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17

A pro‐inflammatory signature mediates FGF2‐induced angiogenesis

Germán Andrés, Daria Leali, Stefania Mitola et al. · Journal of Cellular and Molecular Medicine · 2008 · 71 citations · Full text

Life Sciences, Cell Biology, Immunology +17